We carried out a digital search in the two scientific databases Medline (PubMed interface) and Scopus, using the following keywords: “S-PLEX” AND “COVID-19” OR “SARS-CoV-2”, without no language or date (i.e., up to February 17, 2022) restrictions. Four studies (totalling 657 clinical samples) were included in our analysis. The cumulative diagnostic sensitivity was 0.87 (95%CI, 0.83-0.90), the specificity 0.92 (95%CI, 0.89-0.95), the area under the curve (AUC) 0.955 (95%CI, 0.944-0.967), whilst the accuracy was 89.5% (95%CI, 86.9-91.7%). Similar results were obtained when our analysis was restricted to three studies which evaluated SARS-CoV-2 in NPS or saliva, in that the sensitivity was 0.86 (95%CI, 0.81-0.89), the specificity 0.92 (95%CI, 0.88-0.95), the AUC 0.950 (95%CI, 0.934-0.966) and the accuracy 88.7% (85.7-91.3%), respectively. The results of our critical literature review and pooled analysis confirm that the ultrasensitive S-PLEX SARS-CoV-2 N electrochemiluminescence immunoassay displays excellent performance for detecting SARS-CoV-2 N antigen in a vast array of clinical specimens (NPS, saliva and even plasma), exhibiting a cumulative diagnostic sensitivity as high as 87%, which would make it one of the most sensitive SARS-CoV-2 antigen tests currently available in the market.

Diagnostic accuracy of the ultrasensitive S-PLEX SARS-CoV-2 N electrochemiluminescence immunoassay

Lippi, Giuseppe
;
Montagnana, Martina;
2022

Abstract

We carried out a digital search in the two scientific databases Medline (PubMed interface) and Scopus, using the following keywords: “S-PLEX” AND “COVID-19” OR “SARS-CoV-2”, without no language or date (i.e., up to February 17, 2022) restrictions. Four studies (totalling 657 clinical samples) were included in our analysis. The cumulative diagnostic sensitivity was 0.87 (95%CI, 0.83-0.90), the specificity 0.92 (95%CI, 0.89-0.95), the area under the curve (AUC) 0.955 (95%CI, 0.944-0.967), whilst the accuracy was 89.5% (95%CI, 86.9-91.7%). Similar results were obtained when our analysis was restricted to three studies which evaluated SARS-CoV-2 in NPS or saliva, in that the sensitivity was 0.86 (95%CI, 0.81-0.89), the specificity 0.92 (95%CI, 0.88-0.95), the AUC 0.950 (95%CI, 0.934-0.966) and the accuracy 88.7% (85.7-91.3%), respectively. The results of our critical literature review and pooled analysis confirm that the ultrasensitive S-PLEX SARS-CoV-2 N electrochemiluminescence immunoassay displays excellent performance for detecting SARS-CoV-2 N antigen in a vast array of clinical specimens (NPS, saliva and even plasma), exhibiting a cumulative diagnostic sensitivity as high as 87%, which would make it one of the most sensitive SARS-CoV-2 antigen tests currently available in the market.
S-PLEX, SARS-CoV-2, immunoassay
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11562/1059540
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? ND
social impact